Diabetes Clinical Trials in Phoenix

Showing 241-260 of 554 trials

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

NCT03511898

This study is conducted to evaluate the safety of a single intravitreal injection of THR-149.

Diabetes MellitusDiabetic RetinopathyDiabetic Macular Edema

ThromboGenics12 participantsStarted May 2018

Phoenix, Arizona, United States • Boston, Massachusetts, United States • Reno, Nevada, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

NCT01885208

This trial is conducted in Europe and North and South America. The aim of the trial is to investigate the efficacy and safety of semaglutide once-weekly versus exenatide ER (extended release) 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S813 participantsStarted Dec 2013

Anniston, Alabama, United States • Birmingham, Alabama, United States • Pell City, Alabama, United States +143 more locations

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Diabetes Trials in Other Cities

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Community-Based Participatory Research to Improve Health and Quality of Life of Latino Youth: Every Little Step Counts

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

CANVAS - CANagliflozin cardioVascular Assessment Study

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Other Conditions in Phoenix